Hims & Hers Health, Inc. is a publicly traded consumer health platform and one of the most recognized names in U.S. telehealth. Its testosterone program offers a distinctive approach compared to most TRT providers on this list — centered on enclomiphene-based treatments that stimulate the body's natural testosterone production, and KYZATREX®, an FDA-approved branded oral testosterone, rather than traditional injectable replacement therapy.
With all-inclusive pricing from $99/month, at-home lab testing, licensed provider consultations, and 24/7 care access, Hims offers a frictionless entry point for men exploring testosterone support. Its scale — a large vetted clinician network, broad state availability, and a dedicated mobile platform — makes it one of the most accessible options in the space.
For men who prefer a needle-free approach to testosterone support, are new to the category, or want to explore whether natural stimulation is the right first step before pursuing traditional TRT, Hims represents a well-supported, clinically structured option in 2026.
Founded in 2017 and headquartered in San Francisco, Hims & Hers Health, Inc. is a publicly traded telehealth company with a mission to make healthcare more accessible and personalized. The platform serves millions of customers across men's and women's health, offering treatments across sexual health, dermatology, mental health, weight management, and hormone health through a network of rigorously vetted, licensed healthcare providers.
Hims' testosterone program connects patients with licensed clinicians through an online consultation model. Lab testing is ordered through CLIA-certified labs as part of the visit, and treatment options — if clinically appropriate — are prescribed and shipped directly to the patient. The platform's testosterone offering includes enclomiphene, enclomiphene combined with tadalafil, FDA-approved oral KYZATREX®, and injectable testosterone, giving patients and providers multiple clinically supported options to match individual circumstances.
• All-inclusive testosterone support plans from $99/month — labs, treatment, and provider messaging included
• FDA-approved oral testosterone KYZATREX® — an exclusive platform collaboration with Marius Pharmaceuticals
• Enclomiphene-based treatment that preserves fertility while supporting natural testosterone production
• One of the largest vetted clinician networks in U.S. telehealth with broad state availability
• 24/7 provider access and asynchronous consultation model for maximum convenience
Hims has invested heavily in creating one of the most frictionless onboarding experiences in telehealth. Patients complete an online intake form, receive an at-home lab collection kit, and submit results through the Hims portal — with no live appointment required in most states. A licensed physician reviews the submission and responds within 1–3 business days. If approved, prescriptions are shipped directly to the patient's door. The entire process is manageable through the Hims website or mobile app, designed around convenience and minimal time commitment.
Hims operates as a publicly traded company (NYSE: HIMS) subject to regulatory and financial disclosure obligations, and partners exclusively with licensed, rigorously vetted healthcare providers. Lab testing is processed through CLIA-certified facilities, and KYZATREX® is an FDA-approved medication — distinguishing it from compounded alternatives. The platform's scale, regulatory standing, and clinician vetting processes reflect a level of institutional accountability not always present among smaller TRT telehealth providers.
Hims' all-inclusive pricing starts at $99/month on a 10-month plan, covering lab testing, medication, provider consultation, and shipping with no separate fees. For men prioritizing needle-free treatment or natural testosterone stimulation, this represents one of the more cost-transparent options in the market. The availability of FDA-approved KYZATREX® oral testosterone — rather than compounded alternatives — also provides added value for patients who prefer a fully regulated treatment pathway.
1. Visit the Hims website and complete the online testosterone health intake form.
2. A licensed healthcare provider orders at-home lab testing through a CLIA-certified lab as part of your visit.
3. Complete your at-home sample collection and return the kit using the pre-paid packaging provided.
4. A licensed physician reviews your lab results and medical history and responds within 1–3 business days.
5. If clinically eligible, your prescription is shipped directly to your door and ongoing provider messaging is available throughout your treatment.
Hims is available in most U.S. states, with video consultations required in states where live physician interaction is mandated. State availability should be confirmed on the official Hims website before enrolling. FSA and HSA payments are accepted.
Hims includes 24/7 provider messaging as part of all testosterone plan tiers, with ongoing access to the clinical team for questions about lab results, treatment progress, and dosage. The platform's scale supports fast response times, and the asynchronous model means patients can communicate with their care team without scheduling live appointments. Educational resources, FAQs, and a dedicated patient portal complement the clinical support available throughout the program.
Hims is consistently recognized for the simplicity and speed of its intake process, the clarity of its pricing, and the accessibility of its clinician network. Users frequently highlight the convenience of the asynchronous consultation model — the ability to complete the entire process online, on their own schedule, without live appointments. The Hims mobile platform and portal are well-regarded for ease of navigation, prescription tracking, and provider communication.
Hims offers one of the most accessible and well-structured entry points into clinically supervised testosterone support available in 2026. With FDA-approved KYZATREX® oral testosterone, fertility-preserving enclomiphene options, injectable testosterone, all-inclusive transparent pricing, and the backing of one of the U.S.'s largest telehealth platforms, Hims is particularly well-suited for men who prefer a needle-free approach, are new to testosterone therapy, or want a convenient, low-friction path to evaluation and treatment.
Hims does not manufacture compounded medications. Compounded drug products, including enclomiphene, are not approved or evaluated for safety, effectiveness, or quality by the FDA. KYZATREX® is FDA-approved and manufactured by Marius Pharmaceuticals. All treatment decisions are made at the sole discretion of licensed healthcare providers following individual evaluation. Testosterone Rx is not available in all 50 states. Individual results may vary. Always consult a qualified healthcare provider to determine whether testosterone therapy is appropriate for your specific health needs.
See what some customers are saying about Hims
Great • 682
We upload 100 to 400 to our website daily, displaying them by default from 'best' to 'worst'.
Everything was handled online and the lab kit arrived quickly. No need to schedule a live call — the doctor reviewed my results and had my prescription ready within a couple of days.
Appreciated that they offer FDA-approved options, not just compounded meds. The pricing is clear and there were no surprise charges on my plan.
The enclomiphene option was perfect for me since I wanted to preserve fertility. Provider explained everything clearly and the process was very straightforward.
Being able to do everything on my own schedule without a live appointment was a big plus. Support team was responsive whenever I had a question.
Pricing is transparent and the portal makes it easy to track prescriptions and message my provider. Would recommend for anyone looking for a low-friction starting point.